2016 – Page 36 – Policy & Medicine

CMS Issues Final 60 Day Payment Rule

Bloomberg Health Law Reporter Outlook 2016 – Issues Driving the Healthcare System

BioSimilars: FDA Panel Overwhelming Recommends Approval of Remicade BioSimilar, Congress Asks Tough Questions of FDA and CMS

An Update on the Nomination of FDA Commissioner Robert Califf

Biosimilars Clinical Studies and Analytical Similarity Summit – Update on Biosimilars

Electronic Health Records and the Meaningful Use Program: Is the End Near?

Life Science Compliance Update, February 2016: Technology and Compliance

Testy Oversight and Government Reform Committee Hearing on Prescription Drug Pricing

Physician Payment Sunshine Act: Open Payments Final 2015 Data Submission and Attestation Help

Open Payments Question & Answer Session on February 9, 2016